480 related articles for article (PubMed ID: 8425189)
1. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
2. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
Laterveer L; van Damme J; Willemze R; Fibbe WE
Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
9. Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-1 alpha.
Benjamin WR; Tare NS; Hayes TJ; Becker JM; Anderson TD
J Immunol; 1989 Feb; 142(3):792-9. PubMed ID: 2643663
[TBL] [Abstract][Full Text] [Related]
10. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
11. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
12. In vivo administration of interleukin 6 delays hematopoietic regeneration in sublethally irradiated mice.
Pojda Z; Aoki Y; Sobiczewska E; Machaj E; Tsuboi A
Exp Hematol; 1992 Aug; 20(7):862-7. PubMed ID: 1628704
[TBL] [Abstract][Full Text] [Related]
13. Influence of IL-10 on murine CFU-pre-B formation.
Fine JS; Macosko HD; Grace MJ; Narula SK
Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
[TBL] [Abstract][Full Text] [Related]
14. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil.
Neta R; Keller JR; Ali N; Blanchette F; Dubois CM
Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029
[TBL] [Abstract][Full Text] [Related]
15. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation.
Morrissey PJ; Conlon P; Braddy S; Williams DE; Namen AE; Mochizuki DY
J Immunol; 1991 Mar; 146(5):1547-52. PubMed ID: 1993845
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of human recombinant interleukin 6 on hemopoietic stem and progenitor cells and circulating blood cells in normal mice.
Pojda Z; Tsuboi A
Exp Hematol; 1990 Oct; 18(9):1034-7. PubMed ID: 2397750
[TBL] [Abstract][Full Text] [Related]
17. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
[TBL] [Abstract][Full Text] [Related]
18. Radioprotection of mice with interleukin-1: relationship to the number of spleen colony-forming units.
Schwartz GN; Patchen ML; Neta R; MacVittie TJ
Radiat Res; 1989 Jul; 119(1):101-12. PubMed ID: 2787916
[TBL] [Abstract][Full Text] [Related]
19. A single low dose of human recombinant interleukin 1 accelerates the recovery of neutrophils in mice with cyclophosphamide-induced neutropenia.
Fibbe WE; van der Meer JW; Falkenburg JH; Hamilton MS; Kluin PM; Dinarello CA
Exp Hematol; 1989 Aug; 17(7):805-8. PubMed ID: 2787754
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment.
Takatsuki F; Okano A; Suzuki C; Miyasaka Y; Hirano T; Kishimoto T; Ejima D; Akiyama Y
Cancer Res; 1990 May; 50(10):2885-90. PubMed ID: 2334892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
